Microsoft to Lose OpenAI Tech Access at AGI Milestone
Discover how Microsoft's access to OpenAI technology will end once Artificial General Intelligence (AGI) is achieved. Learn more about this pivotal partnership clause.
Topic
Partnership
A collection of 42 issues
Volkswagen Boosts EV Infrastructure with Xpeng in China
Volkswagen strengthens its EV infrastructure in China by expanding its partnership with Xpeng, aiming for a larger market presence. Discover the impact of this collaboration.
Xpeng and Volkswagen Join Forces for EV Charging in China
Xpeng Motors partners with Volkswagen to develop an ultra-fast EV charging network in China, boosting their competitive edge in the electric vehicle market.
Major Partnership Unlocks 20,000 Charging Piles in 420 Chinese Cities
Explore a groundbreaking partnership in China, featuring over 20,000 charging piles in 420 cities, boosting electric vehicle accessibility and infrastructure.
MyCarrier Partners with Project44 for Enhanced TMS
MyCarrier secures a five-year deal with Project44 in 2023, integrating Project44’s advanced functionalities into its Transport Management System (TMS).
Google Cloud Partners with Rezolve Ai to Resell Brain Suite
Discover how Google Cloud's partnership with Rezolve Ai to resell the innovative Brain Suite is poised to boost significant revenues. Learn more about this strategic collaboration.
Companies Settle and Explore Collaboration Opportunities
Following a confidential settlement, two companies are set to explore new collaboration opportunities, signaling potential growth and innovation.
Amazon Partners with Anthropic for AI Chip Breakthrough
Amazon ventures into AI chip market with an $8 billion collaboration with Anthropic, marking a significant tech industry shift.
Sangamo Shares Plummet as Pfizer Ends Partnership
Sangamo Therapeutics stock drops 50% following Pfizer's termination of their co-development agreement. Discover the impact on Sangamo's future prospects.
Pfizer Shares Rise Amid Sangamo Partnership Termination
Pfizer shares slightly increased despite ending its collaboration with Sangamo. Explore what this means for investors and the future of biotech cooperation.